» Articles » PMID: 8698813

SPC4, SPC6, and the Novel Protease SPC7 Are Coexpressed with Bone Morphogenetic Proteins at Distinct Sites During Embryogenesis

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 1996 Jul 1
PMID 8698813
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study, we screened for subtilisin-like proprotein convertases (SPCs) that potentially regulate the activation of known growth factors during embryonic development. We isolated a novel protease, SPC7, as well as several known SPCs. SPC7, like SPC1, is expressed ubiquitously throughout development. In contrast, SPC4 and SPC6 exhibit dynamic expression patterns. SPC4 transcripts were initially detected in the granulosa cells of secondary follicles. Shortly after implantation, SPC4 transcripts are localized to extraembryonic cell populations, and at later stages are detected in discrete tissues including the primitive gut, heart, neural tube, and limb buds. Within the limb buds, SPC4 mRNA is most abundant in the apical ectodermal ridge (AER). At later stages of limb development, SPC4 mRNA is strongly expressed in cartilage and in the interdigital mesenchyme. In contrast, high SPC6 mRNA levels are detected in somites, the dorsal surface ectoderm, and in vertebral cartilage primordia. In limb buds, SPC6 is strongly expressed in the AER, and at later stages in dorsal mesenchyme. A comparison of these expression patterns with those of several bone morphogenetic proteins (BMPs) indicates that processing of these growth factors may be limited by the local availability of SPCs.

Citing Articles

The Biology and Clinical Implications of PCSK7.

Sachan V, Susan-Resiga D, Lam K, Seidah N Endocr Rev. 2024; 46(2):281-299.

PMID: 39661471 PMC: 11894536. DOI: 10.1210/endrev/bnae031.


Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease.

Suur B, Chemaly M, Lindquist Liljeqvist M, Djordjevic D, Stenemo M, Bergman O Front Pharmacol. 2022; 13:988561.

PMID: 36188622 PMC: 9520287. DOI: 10.3389/fphar.2022.988561.


The Role of Proprotein Convertases in Upper Airway Remodeling.

Lee S, Yoon J Mol Cells. 2022; 45(6):353-361.

PMID: 35611689 PMC: 9200660. DOI: 10.14348/molcells.2022.0019.


Rare Copy Number Variants Identify Novel Genes in Sporadic Total Anomalous Pulmonary Vein Connection.

Shi X, Cheng L, Jiao X, Chen B, Li Z, Liang Y Front Genet. 2018; 9:559.

PMID: 30532766 PMC: 6265481. DOI: 10.3389/fgene.2018.00559.


PCSK5 mutation in a patient with the VACTERL association.

Nakamura Y, Kikugawa S, Seki S, Takahata M, Iwasaki N, Terai H BMC Res Notes. 2015; 8:228.

PMID: 26055999 PMC: 4467638. DOI: 10.1186/s13104-015-1166-0.


References
1.
Beaubien G, Schafer M, Weihe E, Dong W, Chretien M, Seidah N . The distinct gene expression of the pro-hormone convertases in the rat heart suggests potential substrates. Cell Tissue Res. 1995; 279(3):539-49. DOI: 10.1007/BF00318166. View

2.
Tsuji A, Hine C, Mori K, Tamai Y, Higashine K, Nagamune H . A novel member, PC7, of the mammalian kexin-like protease family: homology to PACE4A, its brain-specific expression and identification of isoforms. Biochem Biophys Res Commun. 1994; 202(3):1452-9. DOI: 10.1006/bbrc.1994.2094. View

3.
Shennan K, Taylor N, Jermany J, Matthews G, Docherty K . Differences in pH optima and calcium requirements for maturation of the prohormone convertases PC2 and PC3 indicates different intracellular locations for these events. J Biol Chem. 1995; 270(3):1402-7. DOI: 10.1074/jbc.270.3.1402. View

4.
Seidah N, Chretien M, Day R . The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie. 1994; 76(3-4):197-209. DOI: 10.1016/0300-9084(94)90147-3. View

5.
Thacker C, Peters K, Srayko M, Rose A . The bli-4 locus of Caenorhabditis elegans encodes structurally distinct kex2/subtilisin-like endoproteases essential for early development and adult morphology. Genes Dev. 1995; 9(8):956-71. DOI: 10.1101/gad.9.8.956. View